DOCSLIB.ORG

Enzyme Screening, Engineering and Application Estela

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Enzyme Screening, Engineering and Application Estela Biotechnological production of galactosides of pharmaceutical interest: enzyme screening, engineering and application 90) - 02 - Estela Castilla Ypas http://hdl.handle.net/10803/565506 Generalitat 472 (28 de Catalunya núm. Rgtre. Fund. ió ADVERTIMENT. L'accés als continguts d'aquesta tesi doctoral i la seva utilització ha de respectar els drets de undac la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials F d'investigació i docència en els termes establerts a l'art. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix l'autorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No s'autoritza la seva reproducció o altres formes d'explotació efectuades amb finalitats de lucre ni la seva comunicació pública des d'un lloc aliè al servei TDX. Tampoc s'autoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs. Universitat Ramon Llull Universitat Ramon ADVERTENCIA. El acceso a los contenidos de esta tesis doctoral y su utilización debe respetar los derechos de la persona autora. Puede ser utilizada para consulta o estudio personal, así como en actividades o G: 59069740 G: materiales de investigación y docencia en los términos establecidos en el art. 32 del Texto Refundido de la . Ley de Propiedad Intelectual (RDL 1/1996). Para otros usos se requiere la autorización previa y expresa de la C.I.F persona autora. En cualquier caso, en la utilización de sus contenidos se deberá indicar de forma clara el nombre y apellidos de la persona autora y el título de la tesis doctoral. No se autoriza su reproducción u otras formas de explotación efectuadas con fines lucrativos ni su comunicación pública desde un sitio ajeno al servicio TDR. Tampoco se autoriza la presentación de su contenido en una ventana o marco ajeno a TDR (framing). Esta reserva de derechos afecta tanto al contenido de la tesis como a sus resúmenes e índices. WARNING . The access to the contents of this doctoral thesis and its use must respect the rights of the author. It can be used for reference or private study, as well as research and learning activities or materials in the terms established by the 32nd article of the Spanish Consolidated Copyright Act (RDL 1/1996). Express and previous authorization of the author is required for any other uses. In any case, when using its content, full name of the author and title of the thesis must be clearly indicated. Reproduction or other forms of for profit use or public communication from outside TDX service is not allowed. Presentation of its content in a window or frame external to TDX (framing) is not authorized either. These rights affect both the content of the thesis and its abstracts and indexes. C. Claravall, 1-3 | 08022 Barcelona | Tel. 93 602 22 00 | Fax 93 602 22 49 | [email protected] | www.url.edu 90) - 02 - de Catalunya núm. 472 (28 472 núm. Catalunya de DOCTORAL THESIS Generalitat Generalitat Title Biotechnological production of galactosides of pharmaceutical interest: enzyme screening, engineering and application Rgtre. Fund. Rgtre. Fundació Fundació Presented by Estela Castilla Ypas Universitat Ramon Llull Llull Ramon Universitat Centre IQS School of Engineering G: 59069740 59069740 G: . Department Bioengineering C.I.F Directed by Dr. Antoni Planas and Dra. Teresa Pellicer C. Claravall, 1-3 | 08022 Barcelona | Tel. 93 602 22 00 | Fax 93 602 22 49 | [email protected] | www.url.edu Per tots aquells que ho han fet possible. I especialment per als meus pares. Eloi i Rosa, va per vosaltres. “…amar la trama más que el desenlace” 5 Acknowledgments Un cop s’arriba al final d’una etapa és important mirar enrere, fer balanç i recalcar- ne allò més important. Després d’aquests 4 anys de doctorat he après infinitat de coses i puc dir que he crescut com a científica i com a persona. Aquest apartat intenta agrair i recalcar tot allò que he guanyat en aquesta época. Primer m’agradaria agrair al Pla del Doctorat Industrial (Agaur i Generalitat de Catalunya) per atorgar-nos aquesta beca. Ha estat una fantàstica oportunitat per conèixer el món de la recerca a la universitat i compartir-ho amb la indústria. També vull agrair a IQS i a Interquim S.A haver-me permès moure’m entre els dos mons amb tanta facilitat i comoditat. Agrair al Dr. Antoni Planas, director d’aquesta tesi, confiar en mi i donar-me la possibilitat de realitzar aquest doctorat en el seu laboratori. Gràcies per les discussions i crítiques, és un plaer aprendre tanta ciència d’algú com tu. Gràcies per fer-me descobrir que el món dels carbohidrats pot donar més energia del que sembla! Agrair a la Dra. Teresa Pellicer, directora d’aquesta tesi, primer de tot per confiar en mi: tan en l‘inici com en el llarg de tota la tesi. Gràcies per tota la ciència que has compartit i per la teva manera tant instructiva d’ensenyar. També m’has ensenyat a veure que més enllà de la ciència, hi ha punts i comes a tindre en compte. Moltes gràcies per fer-me veure molt més que números i enzims! També vull agrair al Dr. Xavier Camps i al Dr. Francisco Marquillas permetre’m conèixer Interquim i el projecte gaxilosa des de ben aprop. Gràcies per confiar en mi i en la biocatàlisi. Gràcies per tant gran oportunitat. També vull donar les gràcies al grup del projecte gaxilosa amb els que he tingut la sort de treballar: ha estat un plaer treballar amb vosaltres i veure la investigació des dels ulls de la indústria. Part de lo aconseguit en aquest treball és vostre! Fede, gracias por estar siempre 100% disponible, sé que al final le has cogido cariño a las enzimas. Santos, gracias por tu ayuda, por ensenyarme la parte más industrial del proceso. He aprendido muchísimo en las visitas a los laboratorios de Interquim. Cristina, gràcies per la teva visió analítica: els teus anàlisis han fet palpable els èxits del projecte. També m’agradaria agrair a la Paqui totes les gestions. Moltes gràcies per fer-ho tot TAN fàcil! Thanks to Dr. Charles Tellier to allow me entering to your laboratory and work with you and your team. It was a wonderful opportunity and a great experience. Merci beaucoup pour tout! 6 Gracias, también, al Dr. Alberto Marina por darme la posibilidad de acercarme al complicado, pero apasionante, mundo de la cristalografía. Fue todo un reto para mí! Gracias por todos los resultados compartidos! També vull agrair al tribunal haver acceptat llegir i avaluar aquest treball. Espero que sigui una lectura agradable i en disfruteu tan com jo.// Thanks to the jury for accepting the evaluation of this work. I hope you a nice lecture and I hope you enjoy it as I much as I did. Donar les gràcies a la Dra. Magda Faijes. Podria dir que el doctorat va començar amb tu durant el master en bioenginyeria. Gràcies pel teu entusiasme per la ciència i les ganes de saber més. Durant el master vas transmetre les ganes d’apendre i descrobir que sempre tens, i ho has mantingut durant aquest 4 anys on hem compartit laboratori, seminaris i reunions. Encara recordo aquell dinar on, crec, vaig començar a buscar doctorats. Moltes gràcies! Gràcies al Dr. Xevi Biarnés. Agrair la teva entrega del 100% a bioquímica. Saps que això no seria el mateix sense tu i els teus ulls computacionals. Gràcies per compartir les teves idees i punts de vista. T‘agraeixo les aportacions que has fet en aquest treball. Al teu costat sempre se n’aprèn moltíssim!! Moltes gràcies! Agrair a diferents investigadors amb els que he pogut compartir hores al laboratori i aprendre, cada dia, de cada un de vosaltres: Amanda (gràcies per fer-nos començar el dia sempre amb un somriure), Dra. Marta Palomo (gràcies per demostrar que amb ganes, tot es pot), Dr. Xavi Pérez (gràcies per compartir tants coneixements d’anàlisi!), Dr. Edu Andrés (gracias por tus consejos en el mundo glicosintasa), Dr. Régis Fauré (thanks for you help during your stay, your desire to collaborate and share science. And thanks for the science you share with us, it was very helpful. Merci beaucoup!). Així com investigadors d’altres departaments com la Dr. Gemma Gotor i la Dra. Cristina Ribas, per ajudar sempre amb els problemes cromatogràfics! Als diferents professors i col·laboradors de bioquímica: Dr. Pau Leiva, Dr. Marc Carnicer i Patri. Han estat 3-4 anys amb vosaltres compartint seminaris, pica-pica, reunions i dinars. Ha estat un plaer treballar al vostre costat. Gràcies per la vostra ajuda i idees! He après molt de vosaltres! Que seria de quaselvol doctorat sense els cafés al bar de l’IQS... moltes gràcies a tot l’equip per fer d’aquests breaks una festa continua!! Per descomptat també agrair al personal d’IQS, recepció, reprografia, manteniment i magatzem, la disposició a solucionar imprevistos i resoldre embolics. Gràcies per fer el dia a dia més fàcil! I també més entretingut! 7 Durant aquests 4 anys he tingut la sort de compartir laboratori amb un munt gent, i de cada un d’ells me n’he quedat alguna cosa, amb o sense el seu permís. Cris (Dra. Val) fuiste un ejemplo a seguir, y demostraste que la maña siempre puede más que la fuerza.
Load more

Recommended publications
  • • Glycolysis • Gluconeogenesis • Glycogen Synthesis
    Carbohydrate Metabolism! Wichit Suthammarak – Department of Biochemistry, Faculty of Medicine Siriraj Hospital – Aug 1st and 4th, 2014! • Glycolysis • Gluconeogenesis • Glycogen synthesis • Glycogenolysis • Pentose phosphate pathway • Metabolism of other hexoses Carbohydrate Digestion! Digestive enzymes! Polysaccharides/complex carbohydrates Salivary glands Amylase Pancreas Oligosaccharides/dextrins Dextrinase Membrane-bound Microvilli Brush border Maltose Sucrose Lactose Maltase Sucrase Lactase ‘Disaccharidase’ 2 glucose 1 glucose 1 glucose 1 fructose 1 galactose Lactose Intolerance! Cause & Pathophysiology! Normal lactose digestion Lactose intolerance Lactose Lactose Lactose Glucose Small Intestine Lactase lactase X Galactose Bacteria 1 glucose Large Fermentation 1 galactose Intestine gases, organic acid, Normal stools osmotically Lactase deficiency! active molecules • Primary lactase deficiency: อาการ! genetic defect, การสราง lactase ลด ลงเมออายมากขน, พบมากทสด! ปวดทอง, ถายเหลว, คลนไสอาเจยนภาย • Secondary lactase deficiency: หลงจากรบประทานอาหารทม lactose acquired/transient เชน small bowel เปนปรมาณมาก เชนนม! injury, gastroenteritis, inflammatory bowel disease! Absorption of Hexoses! Site: duodenum! Intestinal lumen Enterocytes Membrane Transporter! Blood SGLT1: sodium-glucose transporter Na+" Na+" •! Presents at the apical membrane ! of enterocytes! SGLT1 Glucose" Glucose" •! Co-transports Na+ and glucose/! Galactose" Galactose" galactose! GLUT2 Fructose" Fructose" GLUT5 GLUT5 •! Transports fructose from the ! intestinal lumen into enterocytes!
    [Show full text]
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Structure, Function, and Regulation of Intestinal Lactase-Phlorizin Hydrolase and Sucrase- Isomaltase in Health and Disease
    Gastrointestinal Functions, edited by Edgard E. Delvin and Michael J. Lentze. Nestle Nutrition Workshop Series, Pediatric Program, Vol. 46. Nestec Ltd.. Vevey/Lippincott Williams & Wilkins. Philadelphia © 2001. Structure, Function, and Regulation of Intestinal Lactase-Phlorizin Hydrolase and Sucrase- Isomaltase in Health and Disease Hassan Y. Nairn Department of Physiological Chemistry, School of Veterinary Medicine Hannover, Hannover, Germany Carbohydrates are essential constituents of the mammalian diet. They occur as oligosaccharides, such as starch and cellulose (plant origin), as glycogen (animal origin), and as free disaccharides such as sucrose (plant) and lactose (animal). These carbohydrates are hydrolyzed in the intestinal lumen by specific enzymes to mono- saccharides before transport across the brush border membrane of epithelial cells into the cell interior. The specificity of the enzymes is determined by the chemical structure of the carbohydrates. The monosaccharide components of most of the known carbohydrates are linked to each other in an a orientation. Examples of this type are starch, glycogen, sucrose, and maltose. (3-Glycosidic linkages are minor. Nevertheless, this type of covalent bond is present in one of the major and most essential carbohydrates in mammalian milk, lactose, which constitutes the primary diet source for the newborn. The enzymes implicated in the digestion of carbohydrates in the intestinal lumen are membrane-bound glycoproteins that are expressed at the apical or microvillus membrane of the enterocytes (1-3). In this chapter, the structural and biosynthetic features of the most important disaccharidases, sucrase-isomaltase and lac- tase-phlorizin hydrolase, and the molecular basis of sugar malabsorption (i.e., en- zyme deficiencies) are discussed.
    [Show full text]
  • Nanor:Noles C/Mg Protein
    Lawrence Berkeley National Laboratory Recent Work Title INTERRELATIONSHIP OF GLYCOGEN METABOLISM AND LACTOSE SYNTHESIS IN MAMMARY EPITHELIAL CELLS OF MICE Permalink https://escholarship.org/uc/item/2r05952r Author Emerman, J.T. Publication Date 1979-10-01 eScholarship.org Powered by the California Digital Library University of California LBL-9894~. d. {/ Preprint ITlI Lawrence Berkeley Laboratory .-;:I UNIVERSITY OF CALIFORNIA CHEMICAL BIODYNAMICS DIVISION Submitted to the Journal of Biological Chemistry -- INTERRELATIONSHIP OF GLYCOGEN METABOLISM AND LACTOSE SYNTHESIS IN MAMMARY EPITHELIAL CELLS OF MICE Joanne .T. Emerman, Jack C. Bartley, and Mina J. Bissell October 1979 RECEIVED LAWRENCE TWO-W E,K LOAN COpy LIBRARY )lIND DOCUMENT.S SEeT!G This is a Library Circulatin9 Copy which may be borrowed for two weeks. For a personal retention" ~, copy, call Tech. Info. Diuision, "Ext. .. 6782 . - "'; . , f.·l~ " /(, Prepared for the U.S. Department of Energy under Contract W-7405-ENG-48 DISCLAIMER This document was prepared as an account of work sponsored by the United States Government. While this document is believed to contain correct information, neither the United States Government nor any agency thereof, nor the Regents of the University of California, nor any of their employees, makes any warranty, express or implied, or assumes any legal responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by its trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof, or the Regents of the University of California.
    [Show full text]
  • Carbohydrate Metabolism
    CARBOHYDRATE METABOLISM By Prof. Dr SOUAD M. ABOAZMA MEDICAL BIOCHEMISTRY DEP. Digestion of carbohydrate The principle sites of carbohydrate digestion are the mouth and small intestine. The dietary carbohydrate consist of : • polysaccharides : Starch, glycogen and cellulose • Disaccharides : Sucrose and Lactose • Monosaccharides : Mainly glucose and fructose monosaccharides need no digestion prior to absorption, wherease disaccharides and polysaccharides must be hydrolysed to simple sugars before their absorption. DIGESTION OF CARBOHYDRATE •Salivary amylase partially digests starch and glycogen to dextrin and few maltoses. It acts on cooked starch. •Pancreatic amylase completely digests starch, glycogen, and dextrin with help of 1: 6 splitting enzyme into maltose and few glucose. It acts on cooked and uncooked starch. Amylase enzyme is hydrolytic enzyme responsible for splitting α 1: 4 glycosidic link. •Cellulose is not digested due to absence of β-glucosidase •Maltase, lactase and sucrase are enzymes secreted from intestinal mucosa, which hydrolyses the corresponding disaccharides to produce glucose, fructose, and galactose. •HCl secreted from the stomach can hydrolyse the disaccharides and polysaccharides. ABSORPTION OF MONOSACCHARIDES •Simple absorption (passive diffusion): The absorption depends upon the concentration gradient of sugar between intestinal lumen and intestinal mucosa. This is true for all monosaccharides especially fructose & pentoses. •Facilitative diffusion by Na+-independent glucose transporter system (GLUT5). There are mobile carrier proteins responsible for transport of fructose, glucose, and galactose with their conc. gradient. •Active transport by sodium-dependent glucose transporter system (SGLUT1). In the intestinal cell membrane there is a mobile carrier protein coupled with Na+- K+ pump. The carrier protein has 2 separate sites one for Na+ ,the other for glucose.
    [Show full text]
  • The Comparison of Commercially Available Β-Galactosidases for Dairy Industry: Review
    FOOD SCIENCE DOI:10.22616/rrd.23.2017.032 THE COMPARISON OF COMMERCIALLY AVAILABLE β-GALACTOSIDASES FOR DAIRY INDUSTRY: REVIEW Kristine Zolnere, Inga Ciprovica Latvia University of Agriculture [email protected] Abstract β-Galactosidase (EC 3.2.1.23) is one of the widely used enzymes for lactose-free milk production and whey permeate treatment. Enzymes can be obtained from microorganisms, plants and animals. Nowadays, microorganisms are becoming an important source for production of commercially available enzymes, which are of great interest and offer several advantages such as easy handling and high production yield. The aim of this review was to summarize findings of research articles on the application of commercially available β-galactosidase preparates in dairy industry, to analyse and compare the most suitable β-galactosidase commercial preparates for lactose hydrolysis. The results showed that the main factor to choose an appropriate β-galactosidase for lactose hydrolysis was reaction condition. Enzymes from microorganisms contain a wide range of optimal pH from 4.0 (Penicillium simplicissimum and Aspergillus niger) to 8.5 (Bacillus subtilis). The greatest commercial potential have enzymes obtained from fungi (Aspergillus oryzae and Aspergillus niger) and yeasts (Kluyveromyces lactis and Kluyveromyces fragilis). Fungal origin enzymes are more suitable for the hydrolysis of lactose in acid whey due to its acidic pH but yeasts origin enzymes for milk and sweet whey. In the study, commercial preparates from different suppliers with the purpose to analyse their lactose hydrolysis potential and give more detailed characteristics of each preparate advantages and drawbacks were also summarized. Key words: β-Galactosidase, lactose hydrolysis, commercial preparates.
    [Show full text]
  • A Review on Bioconversion of Agro-Industrial Wastes to Industrially Important Enzymes
    bioengineering Review A Review on Bioconversion of Agro-Industrial Wastes to Industrially Important Enzymes Rajeev Ravindran 1,2, Shady S. Hassan 1,2 , Gwilym A. Williams 2 and Amit K. Jaiswal 1,* 1 School of Food Science and Environmental Health, College of Sciences and Health, Dublin Institute of Technology, Cathal Brugha Street, D01 HV58 Dublin, Ireland; [email protected] (R.R.); [email protected] (S.S.H.) 2 School of Biological Sciences, College of Sciences and Health, Dublin Institute of Technology, Kevin Street, D08 NF82 Dublin, Ireland; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +353-1402-4547 Received: 5 October 2018; Accepted: 26 October 2018; Published: 28 October 2018 Abstract: Agro-industrial waste is highly nutritious in nature and facilitates microbial growth. Most agricultural wastes are lignocellulosic in nature; a large fraction of it is composed of carbohydrates. Agricultural residues can thus be used for the production of various value-added products, such as industrially important enzymes. Agro-industrial wastes, such as sugar cane bagasse, corn cob and rice bran, have been widely investigated via different fermentation strategies for the production of enzymes. Solid-state fermentation holds much potential compared with submerged fermentation methods for the utilization of agro-based wastes for enzyme production. This is because the physical–chemical nature of many lignocellulosic substrates naturally lends itself to solid phase culture, and thereby represents a means to reap the acknowledged potential of this fermentation method. Recent studies have shown that pretreatment technologies can greatly enhance enzyme yields by several fold.
    [Show full text]
  • What Is Lactose Intolerance? Lactose Intolerance Means You Have Symptoms Such As Bloating, Diarrhea, and Gas After You Have Milk Or Milk Products
    What is lactose? Lactose* is a sugar found in milk and milk products. The small intestine produces lactase, an enzyme that breaks down lactose. The small intestine is an organ that breaks down the food you eat. Enzymes are proteins that help to cause chemical changes in the body. What is lactose intolerance? Lactose intolerance means you have symptoms such as bloating, diarrhea, and gas after you have milk or milk products. If your small intestine does not produce much lactase, you cannot break down much lactose. Lactose that does not break down goes to your colon. The colon is an organ that absorbs water from stool and changes it from a liquid to a solid form. In your colon, bacteria that normally live in the colon break down the lactose and create fluid and gas, causing you to have symptoms. *See the Pronunciation Guide for tips on how to say the words in bold type. What I need to know about Lactose Intolerance 1 The causes of low lactase in your small intestine can include the following: ● In some people, the small intestine makes less lactase starting at about age 2, which may lead to symptoms of lactose intolerance. Other people start to have symptoms later, when they are teenagers or adults. ● Infection, disease, or other problems that harm the small intestine can cause low lactase levels. Low lactase levels can cause you to become lactose intolerant until your small intestine heals. ● Being born early may cause babies to be lactose intolerant for a short time after they are born.
    [Show full text]
  • (12) STANDARD PATENT (11) Application No. AU 2015215937 B2 (19) AUSTRALIAN PATENT OFFICE
    (12) STANDARD PATENT (11) Application No. AU 2015215937 B2 (19) AUSTRALIAN PATENT OFFICE (54) Title Metabolically engineered organisms for the production of added value bio-products (51) International Patent Classification(s) C12N 15/52 (2006.01) C12P 19/26 (2006.01) C12P 19/18 (2006.01) C12P 19/30 (2006.01) (21) Application No: 2015215937 (22) Date of Filing: 2015.08.21 (43) Publication Date: 2015.09.10 (43) Publication Journal Date: 2015.09.10 (44) Accepted Journal Date: 2017.03.16 (62) Divisional of: 2011278315 (71) Applicant(s) Universiteit Gent (72) Inventor(s) MAERTENS, Jo;BEAUPREZ, Joeri;DE MEY, Marjan (74) Agent / Attorney Griffith Hack, GPO Box 3125, Brisbane, QLD, 4001, AU (56) Related Art Trinchera, M. et al., 'Dictyostelium cytosolic fucosyltransferase synthesizes H type 1 trisaccharide in vitro', FEBS Letters, 1996, Vol. 395, pages 68-72 GenBank accession no. AF279134, 6 May 2002 van der Wel, H. et al., 'A bifunctional diglycosyltransferase forms the Fuc#1,2Gal#1,3-disaccharide on Skpl in the cytoplasm of Dictyostelium', The Journal of Biological Chemistry, 2002, Vol. 277, No. 48, pages 46527-46534 WO 2010/070104 Al Abstract The present invention relates to genetically engineered organisms, especially microorganisms such as bacteria and yeasts, for the production of added value bio-products such as specialty saccharide, activated saccharide, nucleoside, glycoside, glycolipid or glycoprotein. More specifically, the present invention relates to host cells that are metabolically engineered so that they can produce said valuable specialty products in large quantities and at a high rate by bypassing classical technical problems that occur in biocatalytical or fermentative production processes.
    [Show full text]
  • Epithelial Cells of Mice
    Biochem. J. (1980) 192, 695-702 695 Printed in Great Britain Interrelationship of glycogen metabolism and lactose synthesis in mammary epithelial cells of mice Joanne T. EMERMAN*, Jack C. BARTLEYt and Mina J. BISSELL Laboratory ofChemical Biodynamics, Lawrence Berkeley Laboratory, University ofCalifornia, Berkeley, CA 94720, U.S.A.t (Received 9 May 1980/Accepted 21 July 1980) Glycogen metabolism in mammary epithelial cells was investigated (i) by studying the conversion of glucose into glycogen and other cellular products in these cells from virgin, pregnant and lactating mice and (ii) by assaying the enzymes directly involved with glycogen metabolism. We find that: (1) mammary epithelial cells synthesized glycogen at rates up to over 60% that of the whole gland; (2) the rate of this synthesis was modulated greatly during the reproductive cycle, reaching a peak in late pregnancy and decreasing rapidly at parturition, when abundant synthesis of lactose was initiated; (3) glycogen synthase and phosphorylase activities reflected this modulation in glycogen metabolism; (4) lactose synthesis reached a plateau during late pregnancy, even though lactose synthase is reported to increase in the mouse mammary gland at this time. We propose that glycogen synthesis restricts lactose synthesis during late pregnancy by competing successfully for the shared UDP-glucose pool. The physiological advantage of glycogen accumulation during late pregnancy is discussed. The significance of glycogen metabolism in possibly because the cultures were known to be mammary epithelial cells has not been considered contaminated with other types of cells. seriously. Putative glycogen granules have been In a preliminary study on the metabolic patterns identified in these cells in the dog (Sekri & Faulkin, of the mammary gland at different stages of the 1967), cow (Reid & Chandler, 1973) and human reproductive cycle, we found that glands from (Sterling & Chandler, 1977).
    [Show full text]
  • Building a Glycosylation Platform in E. Co/I Through Metabolic Engineering Frederik De Bruyn
    Building a Glycosylation Platform in E. co/i through Metabolic Engineering Frederik De Bruyn Examination committee Prof. dr. ir. Paul Van Der Meeren (Ghent University, Chair) Prof. dr. ir. Matthias D'hooghe (Ghent University) Prof. dr. Magda Faijes (Universitat Ramon Llull, Spain) Prof. dr. ir. Els Van Damme (Ghent University) dr. ir. Manu De Groeve (Ablynx) Prof. dr. ir. Wim Soetaert (Ghent University) Prof. dr. ir. Marjan De Mey (Ghent University) Supervisors Prof. dr. ir. Wim Soetaert (Ghent University) Prof. dr. ir. Marjan De Mey (Ghent University) Department of Biochemical and Microbial Technology, Center of Expertise – Industrial Biotechnology and Biocatalysis, Ghent University Dean Prof. dr. ir. Guido Van Huylenbroeck Rector Prof. dr. Anne De Paepe Ghent University Faculty of Bioscience Engineering Department of Biochemical and Microbial Technology Building a Glycosylation Platform in E. coli through Metabolic Engineering Frederik De Bruyn Thesis submitted for the fulfillment of the requirements For the degree of Doctor (PhD) in Applied Biological Sciences Academic year: 2014-2015 Dutch translation of the title: Ontwikkeling van een glycosyleringsplatform in E. coli door Metabolic Engineering To refer to this thesis: De Bruyn, F. (2014) Building a Glycosylation Platform in E. coli through Metabolic Engineering. PhD thesis, Faculty of Bioscience Engineering, Ghent University, Ghent. Cover illustration: ©iStockphoto.com Edited by Brecht De Paepe and Frederik De Bruyn ISBN 978-90-5989-744-1 Copyright © 2014 by Frederik De Bruyn. All rights reserved The author and the promotors give the authorization to consult and to copy parts of this work for personal use only. Every other use is subject to the copyright laws.
    [Show full text]
  • Milk Biosynthesis
    FairLife: Cold Filtration • https://www.youtube.com/watch?v=YgHFaNVofY8 Milk Biosynthesis Part 5: Lactose, Mineral, and Vitamin Secretion Lactose is… • The major carbohydrate in milk • Present in milk of most mammals • A readily digestible source of glucose for the neonate • Digested by lactase enzyme in neonate • Unique to the mammary gland • The major osmoregulator of milk (draws water into gland) Lactose Concentration • Least variable milk component • High lactose concentration will not exist • More lactose = more water coming into alveolar lumen keeping lactose concentration fairly constant • Low lactose concentration will occur during involution and some illnesses • Remember milk is the only source of water for a neonate so lactose is very important!! What is lactose? • Over 60% of whole body glucose use in the lactating dairy cow is for lactose synthesis • Lactose = 1 molecule glucose + 1 molecule galactose • Glucose alone is the primary substrate for lactose synthesis • One glucose is converted to UDP-glucose, which is converted to one UDP-galactose • Another glucose is used for lactose synthesis without modification • 2 glucoses are required for each lactose molecule synthesized Glucose • Glucose passes across the Golgi membrane into the Golgi lumen by a glucose transporter (GLUT 1) • Presence of GLUT 1 on the Golgi membrane is specific to the mammary epithelial cell • Glucose transport does not require energy, but it is affected by glucose levels in cytoplasm Lactose Synthesis • UDP-galactose is actively transported into the
    [Show full text]